Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.
De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT Cooperation. De Luca G, et al. Among authors: kelbaek h. Am J Cardiol. 2013 May 1;111(9):1295-304. doi: 10.1016/j.amjcard.2013.01.281. Epub 2013 Mar 12. Am J Cardiol. 2013. PMID: 23490029 Review.
Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)--a randomized trial comparing a first-generation stent with a second-generation stent.
Jørgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamäki K, Kastrup J, Madsen JK, Kløvgaard L, Thuesen L, Villadsen A, van Weert AW, Reiber JH; Danish multicenter stent study (DANSTENT). Jørgensen E, et al. Among authors: kelbaek h. Am Heart J. 2003 Feb;145(2):e5. doi: 10.1067/mhj.2003.32. Am Heart J. 2003. PMID: 12595860 Clinical Trial.
Randomized comparison of the coil-design Crossflex and the tubular NIR stent.
Thuesen L, Andersen HR, Krusell LR, Bøtker HE, Jørgensen E, Kelbaek H, Kristensen SD; Danstent-2 Study Group. Thuesen L, et al. Among authors: kelbaek h. Catheter Cardiovasc Interv. 2003 May;59(1):8-12. doi: 10.1002/ccd.10499. Catheter Cardiovasc Interv. 2003. PMID: 12720233 Clinical Trial.
The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.
Kelbaek H, Thuesen L, Helqvist S, Kløvgaard L, Jørgensen E, Aljabbari S, Saunamäki K, Krusell LR, Jensen GV, Bøtker HE, Lassen JF, Andersen HR, Thayssen P, Galløe A, van Weert A; SCANDSTENT Investigators. Kelbaek H, et al. J Am Coll Cardiol. 2006 Jan 17;47(2):449-55. doi: 10.1016/j.jacc.2005.10.045. Epub 2005 Dec 9. J Am Coll Cardiol. 2006. PMID: 16412876 Free article. Clinical Trial.
Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H, Helqvist S, Thuesen L, Kløvgaard L, Jørgensen E, Saunamäki K, Krusell LR, Bøtker HE, Engstrøm T, Jensen GV; SCANDSTENT investigators. Kelbaek H, et al. Am Heart J. 2006 Nov;152(5):882-6. doi: 10.1016/j.ahj.2006.03.028. Am Heart J. 2006. PMID: 17070149
Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
Thuesen L, Kelbaek H, Kløvgaard L, Helqvist S, Jørgensen E, Aljabbari S, Krusell LR, Jensen GV, Bøtker HE, Saunamäki K, Lassen JF, van Weert A; SCANDSTENT Investigators. Thuesen L, et al. Among authors: kelbaek h. Am Heart J. 2006 Dec;152(6):1140-5. doi: 10.1016/j.ahj.2006.06.035. Am Heart J. 2006. PMID: 17161067 Clinical Trial.
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Stettler C, et al. Among authors: kelbaek h. Lancet. 2007 Sep 15;370(9591):937-48. doi: 10.1016/S0140-6736(07)61444-5. Lancet. 2007. PMID: 17869634 Review.
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up.
Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators. Busk M, et al. Among authors: kelbaek h. Eur Heart J. 2008 May;29(10):1259-66. doi: 10.1093/eurheartj/ehm392. Epub 2007 Oct 23. Eur Heart J. 2008. PMID: 17956874 Clinical Trial.
404 results